Literature DB >> 31097516

The proportion of lung cancer patients attending UK lung cancer clinics who would have been eligible for low-dose CT screening.

Kathryn Gracie1, Martyn P T Kennedy2, Georgina Esterbrook3, Graham Smith3, Parry Blaxill3, Ali T Ameri3, Kirsty I A Rodger4, Jonathan M Robson4, Elankumaran Paramasivam4, Rehan Naseer5, Peter Smith6, Deborah A B Ellames4, Bana Hawramy4, Matthew E J Callister4.   

Abstract

Entities:  

Year:  2019        PMID： 31097516     DOI： 10.1183/13993003.02221-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  3 in total

1.  Author response.

Authors:  Stephen Bradley
Journal:  Br J Gen Pract       Date:  2022-02-24       Impact factor: 5.386

2.  A Comparison of Web-Based Cancer Risk Calculators That Inform Shared Decision-making for Lung Cancer Screening.

Authors:  Frederick R Kates; Ryan Romero; Daniel Jones; Jacqueline Egelfeld; Santanu Datta
Journal:  J Gen Intern Med       Date:  2021-04-09       Impact factor: 6.473

3.  Yorkshire Lung Screening Trial (YLST): protocol for a randomised controlled trial to evaluate invitation to community-based low-dose CT screening for lung cancer versus usual care in a targeted population at risk.

Authors:  Philip Aj Crosbie; Rhian Gabe; Irene Simmonds; Martyn Kennedy; Suzanne Rogerson; Nazia Ahmed; David R Baldwin; Richard Booton; Ann Cochrane; Michael Darby; Kevin Franks; Sebastian Hinde; Sam M Janes; Una Macleod; Mike Messenger; Henrik Moller; Rachael L Murray; Richard D Neal; Samantha L Quaife; Mark Sculpher; Puvanendran Tharmanathan; David Torgerson; Matthew Ej Callister
Journal:  BMJ Open       Date:  2020-09-10       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.